Trump nominates Robert F. Kennedy Jr. as health secretary, vaccine stocks drop

President-elect Donald Trump has nominated Robert F. Kennedy Jr. as the new head of the Department of Health and Human Services. Kennedy, known for his skepticism about vaccines, recently ended his presidential campaign and endorsed Trump. Kennedy's selection has raised concerns among public health experts, especially given his history of spreading misinformation about vaccines. His appointment could lead to significant changes in health policies and influence agencies like the CDC and FDA. Following the announcement, shares of major vaccine manufacturers fell, reflecting uncertainty about Kennedy's potential impact on health policy. Companies like Moderna, Pfizer, and Johnson & Johnson saw declines in their stock prices.